Gogo Inc. GOGO
2.34 USD -0.19 (-7.51%)
Nov 5, 2026, 11:15 AM EST
2.28 Day range 2.54
1.96 52-week range 7.94
- YTD
- -49.79%
- 1 year
- -73.29%
Analyst view
Consensus: buy
Buy
Price target (mean) 15.00 +541.0% upside
Now 2.34
- Target (low)
- 14.00
- Target (mean)
- 15.00
- Target (high)
- 16.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
- Strong buy0
- Buy2
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.03027 | 0.03 – 0.03054 | -0.22 | +113.8% | 222.99M | +61.8% | 2 |
| Next quarter | 0.105 | 0.09 – 0.12 | 0.09 | +16.7% | 227.00M | -1.4% | 2 |
| Current year | 0.16 | 0.16 – 0.16 | 0.41894 | -61.8% | 903.65M | +103.2% | 1 |
| Next year | 0.4779 | 0.4358 – 0.52 | 0.28404 | +68.3% | 929.07M | +2.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 17, 2025 | Roth MKM | Maintained | Buy | Buy |
| Sep 17, 2024 | Roth MKM | Maintained | Buy | Buy |
| Sep 3, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 8, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Apr 16, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 12, 2023 | Roth MKM | Maintained | Buy | Buy |
| Nov 8, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 14, 2023 | TD Cowen | Maintained | Outperform | Outperform |
| Aug 8, 2023 | Roth MKM | Maintained | Buy | Buy |
| Nov 1, 2022 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Mar 7, 2022 | JP Morgan | Maintained | — | Neutral |
| Oct 7, 2021 | JP Morgan | Upgrade | Underweight | Neutral |
| Oct 6, 2021 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Apr 8, 2021 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| Apr 5, 2021 | William Blair | Upgrade | Market Perform | Outperform |
| Feb 1, 2021 | JP Morgan | Downgrade | Neutral | Underweight |
| Sep 9, 2020 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Mar 24, 2020 | Morgan Stanley | Maintained | — | Underweight |
| May 13, 2019 | Roth Capital | Initiated | — | Buy |
| May 10, 2019 | William Blair | Upgrade | Market Perform | Outperform |
| Apr 18, 2019 | Cowen & Co. | Upgrade | Market Perform | Outperform |
| Jul 24, 2018 | Raymond James | Downgrade | Outperform | Market Perform |
| Jul 17, 2018 | William Blair | Downgrade | Outperform | Market Perform |
| May 30, 2018 | Morgan Stanley | Maintained | Underweight | Underweight |
| May 21, 2018 | UBS | Downgrade | Buy | Neutral |
| Mar 7, 2018 | Guggenheim | Downgrade | Buy | Neutral |
| Feb 23, 2018 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 4, 2017 | Standpoint Research | Downgrade | Buy | Hold |
| May 31, 2017 | Raymond James | Initiated | — | Outperform |
| Jan 25, 2017 | Guggenheim | Initiated | — | Buy |
